11.06.2018 | short communication | Ausgabe 4/2018
Open Access
• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed—mutation rate of the marker higher than expected
Sonja Kappel-Latif, Johannes Zacherl, Michael Hejna, Maria Westerhoff, Dietmar Tamandl, Ahmed Ba-Ssalamah, Martina Mittlböck, Brigitte Wolf, Friedrich Wrba, Irene Kührer, Ursula Pluschnig, Sebastian F. Schoppmann, Reinhold Függer, Ronald Zwrtek, Karl Glaser, Josef Karner, Friedrich Längle, Etienne Wenzl, Rudolf Roka, Dietmar Öfner, Jörg Tschmelitsch, Michael Hold, Felix Keil, Michael Gnant, Daniela Kandioler MD, MBA, the Pancho trialists and for the Medical University of Vienna p53research group
18.05.2018 | case report | Ausgabe 4/2018
Pseudopapillary tumours of the pancreas
A case series and short review of the literature
Mark Portelli MSc, Snezana Bozanic MD, David Pisani MD, Kelvin Cortis FRCR, Jo-Etienne Abela FRCS
